Business Opportunities in Biotech Innovation Associate to leverage cell free sy...
Business Opportunities in Biotech Innovation Associate to leverage cell free synthetic biology
The main objective of BOB is to hire and integrate a highly-committed candidate to build up an innovation strategy at c-LEcta to valorize its unique technology platform by developing an innovation project according to the company...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SynBio4Flav
Synthetic microbial consortia based platform for flavonoids...
7M€
Cerrado
METACODE
Code engineered new to nature microbial cell factories for n...
4M€
Cerrado
SynCrop
Synthetic Circuits for Robust Orthogonal Production
4M€
Cerrado
ProteinFactory
Engineering of new generation protein secretion systems
4M€
Cerrado
DPI2014-55276-C5-1-R
BIOLOGIA SINTETICA PARA LA MEJORA EN BIOPRODUCCION: DISEÑO,...
224K€
Cerrado
Información proyecto BOB
Duración del proyecto: 12 meses
Fecha Inicio: 2019-08-19
Fecha Fin: 2020-09-14
Líder del proyecto
CLECTA GMBH
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
121K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
The main objective of BOB is to hire and integrate a highly-committed candidate to build up an innovation strategy at c-LEcta to valorize its unique technology platform by developing an innovation project according to the company strategy to become a food ingredient producer. The envisaged innovation will help to solve the industrial problem of natural product synthesis, which is today hampered by yield limits, inefficiencies in chemical synthesis, or side-effects. The functional potential of numerous natural products can only be fully exploited if the commercial production at low cost is possible. Synthetic biology is expected to achieve a break-through for increased or cheaper production. c-LEcta has conceptualized a unique technology platform, already demonstrated the concept’s feasibility, and is targeting new molecules for further growth.
However, the innovation team currently lacks of a candidate that comprises excellent technology knowledge in industrial biotechnology and/or food science and innovation management or business administration skills for assessing market values at an early development stage. The German job market is currently marked by a lack of expert personnel, and c-LEcta is experiencing difficulties in receiving high-quality responses to such a position, as it is not visible enough to job-seekers. This will be overcome by a targeted international publication of the vacancy on EURAXESS and beyond. After acquisition of a suitable candidate according to the defined profile, the specific objectives of BOB are: 1) to train the Associate according to a dedicated initiation and advanced training plan (according to the specific needs of the candidate); 2) to identify and assess new target products; and 3) to turn this assessment into an innovation idea and a strategy, deriving at least 1 innovation project. Finally, the Innovation Associate is expected to stay with the company and to strengthen the Innovation and Business development team.